When persistent allergic rhinitis continues to affect quality of life despite an initial round of targeted nasal treatments, a more durable next step is indicated. This page describes the clinical scenario and points to the full structured protocol.
Persistent allergic rhinitis is defined as symptoms occurring more than four days per week and more than four weeks per year. When symptoms at this frequency significantly impair quality of life, clinical guidelines support escalation beyond initial management.
This protocol applies when the previous treatment step — which included options such as nasal irrigation, a decongestant for nasal congestion, ipratropium (Atrovent) for rhinorrhea, or an intranasal antihistamine for nasal and ocular symptoms — failed to achieve resolution of nasal congestion, rhinorrhea, and nasal ocular symptoms.
For persistent symptoms unresolved by the above measures, a form of immunotherapy may be considered as the next step. The full protocol specifies the clinical criteria, patient selection, and complete regimen details.